Cargando…

Natural Docosahexaenoic Acid in the Triglyceride Form Attenuates In Vitro Microglial Activation and Ameliorates Autoimmune Encephalomyelitis in Mice

Many neurodegenerative diseases are associated, at least in part, to an inflammatory process in which microglia plays a major role. The effect of the triglyceride form of the omega-3 polyunsaturated fatty acid docosahexaenoic acid (TG-DHA) was assayed in vitro and in vivo to assess the protective an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mancera, Pilar, Wappenhans, Blanca, Cordobilla, Begoña, Virgili, Noemí, Pugliese, Marco, Rueda, Fèlix, Espinosa-Parrilla, Juan F., Domingo, Joan C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537796/ https://www.ncbi.nlm.nih.gov/pubmed/28665331 http://dx.doi.org/10.3390/nu9070681

Ejemplares similares

K(ATP) Channel Opener Diazoxide Prevents Neurodegeneration: A New Mechanism of Action via Antioxidative Pathway Activation
por: Virgili, Noemí, et al.
Publicado: (2013)

Correction: K(ATP) Channel Opener Diazoxide Prevents Neurodegeneration: A New Mechanism of Action via Antioxidative Pathway Activation
por: Virgili, Noemí, et al.
Publicado: (2013)

Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism
por: Gómez-Soler, Maricel, et al.
Publicado: (2018)

Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2017)

Oral administration of the K(ATP )channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis
por: Virgili, Noemí, et al.
Publicado: (2011)

Inadequate Content of Docosahexaenoic Acid (DHA) of Donor Human Milk for Feeding Preterm Infants: A Comparison with Mother’s Own Milk at Different Stages of Lactation
por: Castillo, Félix, et al.
Publicado: (2021)

Does Coenzyme Q10 Plus Selenium Supplementation Ameliorate Clinical Outcomes by Modulating Oxidative Stress and Inflammation in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
por: Castro-Marrero, Jesús, et al.
Publicado: (2022)

Erythrocyte Membrane Docosahexaenoic Acid (DHA) and Lipid Profile in Preterm Infants at Birth and Over the First Month of Life: A Comparative Study with Infants at Term
por: Castillo Salinas, Félix, et al.
Publicado: (2022)

Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes in Response to Omega-3 Supplementation: A Dose-Response Pilot Study
por: Drobnic, Franchek, et al.
Publicado: (2017)

Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial
por: Ayats-Vidal, Roser, et al.
Publicado: (2023)

Effect of Melatonin Plus Zinc Supplementation on Fatigue Perception in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Castro-Marrero, Jesús, et al.
Publicado: (2021)

A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease
por: Boyer-Diaz, Zoe, et al.
Publicado: (2019)

Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial
por: Rodríguez, Celestino, et al.
Publicado: (2019)

Remodeling of lipid bodies by docosahexaenoic acid in activated microglial cells
por: Tremblay, Marie-Eve, et al.
Publicado: (2016)

Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013)

Promotion of microglial phagocytosis by tuftsin stimulates remyelination in experimental autoimmune encephalomyelitis
por: Bao, Zheng, et al.
Publicado: (2019)

AIM2 controls microglial inflammation to prevent experimental autoimmune encephalomyelitis
por: Ma, Chunmei, et al.
Publicado: (2021)

Antioxidant and Anti-Inflammatory Effects of Oral Supplementation with a Highly-Concentrated Docosahexaenoic Acid (DHA) Triglyceride in Patients with Keratoconus: A Randomized Controlled Preliminary Study
por: Peris-Martínez, Cristina, et al.
Publicado: (2023)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
por: Basler, Michael, et al.
Publicado: (2014)

Amelioration of experimental autoimmune encephalomyelitis by Ishige okamurae
por: Ahn, Meejung, et al.
Publicado: (2018)

Oryeongsan (Goreisan) Ameliorates Experimental Autoimmune Encephalomyelitis
por: Inada, Rino, et al.
Publicado: (2019)

Lipophilic Bioactive Compounds Transported in Triglyceride-Rich Lipoproteins Modulate Microglial Inflammatory Response
por: Espinosa, Juan M., et al.
Publicado: (2022)

Myeloid C/EBPβ deficiency reshapes microglial gene expression and is protective in experimental autoimmune encephalomyelitis
por: Pulido-Salgado, Marta, et al.
Publicado: (2017)

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
por: Stolz, Leonie, et al.
Publicado: (2017)

Carnosol Modulates Th17 Cell Differentiation and Microglial Switch in Experimental Autoimmune Encephalomyelitis
por: Li, Xing, et al.
Publicado: (2018)

Microglial Nox2 Plays a Key Role in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
por: Hu, Chih-Fen, et al.
Publicado: (2021)

Microglial expression of CD83 governs cellular activation and restrains neuroinflammation in experimental autoimmune encephalomyelitis
por: Sinner, Pia, et al.
Publicado: (2023)

Quantitative Proteomics Reveals Docosahexaenoic Acid-Mediated Neuroprotective Effects in Lipopolysaccharide-Stimulated Microglial Cells
por: Yang, Bo, et al.
Publicado: (2020)

Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis
por: Müller, André Michael, et al.
Publicado: (2012)

Silencing miR-150 Ameliorates Experimental Autoimmune Encephalomyelitis
por: Hu, Zhaolan, et al.
Publicado: (2018)

ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
por: Lu, Kaili, et al.
Publicado: (2020)

Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis
por: Sánchez-Fernández, Alba, et al.
Publicado: (2022)

Phenethyl Ester of Gallic Acid Ameliorates Experimental Autoimmune Encephalomyelitis
por: Stegnjaić, Goran, et al.
Publicado: (2022)

Rituximab Therapy Reduces Organ-Specific T Cell Responses and Ameliorates Experimental Autoimmune Encephalomyelitis
por: Monson, Nancy L., et al.
Publicado: (2011)

Bushen Yisui Capsule ameliorates axonal injury in experimental autoimmune encephalomyelitis
por: Fang, Ling, et al.
Publicado: (2013)

Blocking GluR2–GAPDH ameliorates experimental autoimmune encephalomyelitis
por: Zhai, Dongxu, et al.
Publicado: (2015)

RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis
por: Lee, Jae-Kyung, et al.
Publicado: (2016)

IL-12p35 Inhibits Neuroinflammation and Ameliorates Autoimmune Encephalomyelitis
por: Choi, Jin Kyeong, et al.
Publicado: (2017)

Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis
por: Park, Byunghyun, et al.
Publicado: (2023)

Genetic risk prediction of the plasma triglyceride response to independent supplementations with eicosapentaenoic and docosahexaenoic acids: the ComparED Study
por: Vallée Marcotte, Bastien, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_62rlri7du5tlaha9o79lkdbqu6